Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3EAX

Crystal structure PTP1B complex with small molecule compound LZP-6

3EAX の概要
エントリーDOI10.2210/pdb3eax/pdb
関連するPDBエントリー3EB1
分子名称Tyrosine-protein phosphatase non-receptor type 1, 4,4'-piperazine-1,4-diylbis{1-[3-(benzyloxy)phenyl]-4-oxobutane-1,3-dione} (3 entities in total)
機能のキーワードprotein tyrosine phosphatase, ptp1b, inhibitor, acetylation, endoplasmic reticulum, hydrolase, membrane, oxidation, phosphoprotein, polymorphism, protein phosphatase
由来する生物種Homo sapiens (Human)
細胞内の位置Endoplasmic reticulum membrane; Peripheral membrane protein; Cytoplasmic side: P18031
タンパク質・核酸の鎖数1
化学式量合計38012.32
構造登録者
Zhang, Z.-Y.,Liu, S.,Zhang, L.-F.,Yu, X.,Xue, T.,Gunawan, A.M.,Long, Y.-Q. (登録日: 2008-08-26, 公開日: 2009-07-07, 最終更新日: 2024-02-21)
主引用文献Liu, S.,Zeng, L.F.,Wu, L.,Yu, X.,Xue, T.,Gunawan, A.M.,Long, Y.Q.,Zhang, Z.Y.
Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors.
J.Am.Chem.Soc., 130:17075-17084, 2008
Cited by
PubMed Abstract: There has been considerable interest in protein tyrosine phosphatase 1B (PTP1B) as a therapeutic target for diabetes, obesity, as well as cancer. Identifying inhibitory compounds with good bioavailability is a major challenge of drug discovery programs targeted toward PTPs. Most current PTP active site-directed pharmacophores are negatively charged pTyr mimetics which cannot readily enter the cell. This lack of cell permeability limits the utility of such compounds in signaling studies and further therapeutic development. We identify aryl diketoacids as novel pTyr surrogates and show that neutral amide-linked aryl diketoacid dimers also exhibit excellent PTP inhibitory activity. Kinetic studies establish that these aryl diketoacid derivatives act as noncompetitive inhibitors of PTP1B. Crystal structures of ligand-bound PTP1B reveal that both the aryl diketoacid and its dimeric derivative bind PTP1B at the active site, albeit with distinct modes of interaction, in the catalytically inactive, WPD loop open conformation. Furthermore, dimeric aryl diketoacids are cell permeable and enhance insulin signaling in hepatoma cells, suggesting that targeting the inactive conformation may provide a unique opportunity for creating active site-directed PTP1B inhibitors with improved pharmacological properties.
PubMed: 19012396
DOI: 10.1021/ja8068177
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.9 Å)
構造検証レポート
Validation report summary of 3eax
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon